|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Results of a phase Ⅲ, randomized, placebo-controlled study of so- rafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage Ⅲ or stage Ⅳ melanoma 显示文摘 | Hauschild A Agarwala SS Trefzer U | 2009 | J Clin Oncol2009，27，17： | 1 |
| 2 | BREAK-2:a Phase IIA trial of the selective BRAF kinase inhibitor GSK2118436 in patients with BRAF mutation-positive (V600E/K) metastatic melanoma显示文摘 | TREFZER U MINOR D RIBAS A | | 0，，： | 1 |
| 3 | Proteome serological determination of tumor-associated antigens in melanoma显示文摘 | Forgber M Trefzer U Sterry W | 2009 | PLoS One2009，，4： | 1 |
| 4 | Results of a phase In, randomized, placebo-controUed study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma 显示文摘 | Hauschild A Agarwala SS Trefzer U | 2009 | J Clin Oncol2009，27，17： | 1 |
| 5 | Hybrid-cell vaccines for cancer immune therapy显示文摘 | Trefzer U Walden P | 2003 | Mol Biotech2003，25，1： | 1 |
| 6 | Resuhs of a phase Ⅲ, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage Ⅲ or stage Ⅳ melanoma 显示文摘 | Hauschild A Agarwala SS Trefzer U | 2009 | J Clin Oncol2009，27，17： | 1 |
| 7 | Results of a phase Ⅲ, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paelitaxel as second-line treatment in patients with unresectable stagem or stage Ⅳ melanoma 显示文摘 | Hauschild A Agarwala SS Trefzer U | 2009 | J Clin Oncol2009，27，17： | 1 |
| 8 | Results of a phase In, randomized, placebo-controUed study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma 显示文摘 | Hauschild A Agarwala SS Trefzer U | 2009 | J Clin Oncol2009，27，17： | 1 |
| 9 | Hybrid-cell vaccines for cancer immune therapy显示文摘 | Trefzer U Walden P | 2003 | Mol Biotechnol2003，25，1： | 1 |
| 10 | Hybrid cell vaccination for cancer immune therapyfirst clinical trial with metastatic melanoma 显示文摘 | Trefzer U Weingart G Chen Y W | 2000 | Int J Cancer2000，85，： | 1 |
| 11 | Results of a multieenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma 显示文摘 | Eisen T Trefzer U Hamilton A | 2010 | Cancer2010，116，1： | 1 |
| 12 | Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage Ⅲ and IV patients显示文摘 | Trefzer U Herberth G Wohlan K | 2004 | Int J Cancer2004，110，5： | 1 |
| 13 | Tumour- dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological eVects and clinical results 显示文摘 | Trefzer U Herberth G Wohlan K | 2005 | Vaccine2005，23，17： | 1 |
| 14 | Results of a phase Ⅲ,randomized,placebocontrolled stndy of sorafenib in combination with carboplatin and paclitaxel as second line treatment in patients with unresectable stage Ⅲ or stage Ⅴ melanoma显示文摘 | Hauschild A Agarwala SS Trefzer U | 2009 | J Clin Oncol2009，27，17： | 1 |
| 15 | Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results 显示文摘 | Trefzer U Herberth G Wohlan K | 2005 | Vaccine2005，23，1718： | 1 |
| 16 | Tumour- dendritic cell vaccination for the treatment of patients with malignant melanoma : immunological effects and clinical results 显示文摘 | Trefzer U Herberth G Wohlan K | 2005 | Vaccine2005，23，： | 1 |
| 17 | Hybrid-cell vaccines for cancer immune therapy显示文摘 | Trefzer U Walden P | 2003 | Mol Biotechnol2003，25，1： | 1 |
| 18 | SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions显示文摘 | Trefzer U Rietz N Chen Y | 2000 | Arch Dermatol Res2000，292，12： | 1 |
| 19 | The monoclonal antibody SMS-1 recognizes a fibronectin variant which is widely expressed in melanoma显示文摘 | Trefzer U Chen Y W Herberth G | 2006 | BMC Cancer2006，6，： | 1 |
| 20 | Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma:results of a prospective study and review of the literature显示文摘 | Maza S Trefzer U Hofmann M | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员